Research in the group is focused on developing computational methods for variant calling in human genomes (particularly challenging types of variants) using high-throughput DNA sequencing technologies and identifying rare variants in human disease (young-onset diabetes) using a combination of bioinformatics, statistical modeling and large-scale data analysis.